Expertise
Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.
THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM
The PCCTC was formed to address critically unmet needs in prostate cancer. Our mission is to design, implement, and complete process driven clinical trials, translating scientific discoveries to improved standards of care.
The PCCTC is changing how prostate cancer drugs are developed. Our unique infrastructure facilitates project co-development between investigators, clinical research sites and industry partners.
Our Participating Clinical Research Sites
Recent News +++
PCCTC Medical Director Michael Morris, MD Profiled, “A Triumph Against Prostate Cancer”
Press Releases by PCCTC November 28, 2022New technology provides a major step forward in diagnosing and treating prostate cancer.
Learn MoreJUST PUBLISHED—IRONMAN: A Novel International Registry of Men with Advanced Prostate Cancer
Press Releases by PCCTC November 8, 2022A new manuscript published in JCO Global Oncology describes the PCCTC managed IRONMAN Regi...
Learn MoreThe PCCTC at ASCO22
Press Releases by PCCTC June 3, 2022More than 40,000 oncology professionals from around the world will convene at the annual A...
Learn MoreGenetic Testing for Prostate Cancer: Considerations for Practice Virtual Genetics Board
Press Releases by PCCTC March 17, 2022 Learn MoreLantheus Collaborates with The Prostate Cancer Clinical Trial Consortium (PCCTC) To Advance AI-Enabled Imaging Biomarkers in Prostate Cancer
Press Releases by PCCTC January 27, 2022NORTH BILLERICA, MA, January 27, 2022 – Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus...
Learn MoreGenetic Testing for Prostate Cancer: Considerations for Practice Virtual Genetics Board
Press Releases by PCCTC December 8, 2021The Prostate Cancer Clinical Trials Consortium (PCCTC) Genetics Germline Working Group is ...
Learn MoreFollow Us
Led by Dr @xiaoweimd (@DanaFarber), our study of nivolumab + docetaxel + ADT is enrolling eligible patients with me… https://t.co/gN2ZTe5Fpd
PCCTC investigator Dr @Daniel_J_George of @DukeGUCancer discusses antibody drug conjugates in #prostatecancer via… https://t.co/VpRMz7F00W
Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…
2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers
careers.mskcc.org
Committed to world-class science!
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.